2007
DOI: 10.1016/j.pnpbp.2006.08.012
|View full text |Cite
|
Sign up to set email alerts
|

Quetiapine for the treatment of borderline personality disorder; an open-label study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

3
25
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 37 publications
3
25
0
Order By: Relevance
“…Quetiapine was added at 50 mg/day, while mirtazapine was reduced to 30 mg/day. Laboratory tests carried out the following day and 5 days after the start of treatment with quetiapine revealed platelet counts of 100,000/mm 3 and 56,000/mm 3 respectively. Two further measurements were obtained, 8 days and 28 days after discontinuing treatment with quetiapine, showing higher platelet levels of 85,000/mm 3 and 120,000/mm 3 respectively.…”
mentioning
confidence: 99%
See 4 more Smart Citations
“…Quetiapine was added at 50 mg/day, while mirtazapine was reduced to 30 mg/day. Laboratory tests carried out the following day and 5 days after the start of treatment with quetiapine revealed platelet counts of 100,000/mm 3 and 56,000/mm 3 respectively. Two further measurements were obtained, 8 days and 28 days after discontinuing treatment with quetiapine, showing higher platelet levels of 85,000/mm 3 and 120,000/mm 3 respectively.…”
mentioning
confidence: 99%
“…Accordingly, the relative risk of thrombocytopenia can be described as very rare with loxapine and clozapine (o 0.01%), uncommon with risperidone (X 0.1%, o 1%), but very common with quetiapine (X 10%). However, very few cases are reported in the literature, [1][2][3][4] with one published case of idiopathic thrombocytopenic purpura, 1 and it remains unclear whether rechallenge may be considered.…”
mentioning
confidence: 99%
See 3 more Smart Citations